Predictive Oncology

OverviewSuggest Edit

Predictive Oncology, Formerly Precision Therapeutics and Skyline Medical, is a medical device company manufacturing an environmentally conscientious system for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers the STREAMWAY Fluid Waste Management System that suctions surgical waste fluid from the patient using standard surgical tubing. 
TypePublic
Founded2002
HQEagan, US
Websiteprecisiontherapeutics.com

Latest Updates

Employees (est.) (Dec 2018)24(+42%)
Revenue (FY, 2018)$1.4 M(+116%)

Key People/Management at Predictive Oncology

Carl Schwartz

Carl Schwartz

Interim President and Cheif Executive Officer, Director
David Johnson

David Johnson

COO
Bob Myers

Bob Myers

CFO
David Dauwalter

David Dauwalter

Director of Product Management
Rodney Schmidt

Rodney Schmidt

Senior Design Engineer
Show more

Predictive Oncology Office Locations

Predictive Oncology has an office in Eagan
Eagan, US (HQ)
2915 Commers Dr #900
Show all (1)

Predictive Oncology Financials and Metrics

Predictive Oncology Revenue

Predictive Oncology's revenue was reported to be $1.41 m in FY, 2018
USD

Revenue (Q2, 2019)

286.2k

Gross profit (Q2, 2019)

167.8k

Gross profit margin (Q2, 2019), %

58.6%

Net income (Q2, 2019)

1.5m

Cash (30-Jun-2019)

69.6k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

468.1k951.6k654.4k456.5k654.8k1.4m

Revenue growth, %

103%(31%)

Cost of goods sold

189.7k385.3k304.0k181.6k148.0k415.8k

Gross profit

278.4k566.2k350.4k274.9k506.8k995.9k
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

70.2k318.3k397.3k234.0k85.8k96.9k85.4k134.6k175.2k106.8k152.5k411.6k358.6k329.9k255.2k286.2k

Cost of goods sold

31.1k98.4k134.7k83.6k19.8k85.9k36.8k26.5k37.0k22.0k28.7k117.3k109.0k83.0k73.7k118.4k

Gross profit

39.1k219.9k262.5k150.4k66.0k11.0k48.7k108.1k138.2k84.8k123.8k294.3k249.6k246.9k181.5k167.8k

Gross profit Margin, %

56%69%66%64%77%11%57%80%79%79%81%71%70%75%71%59%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

102.0k16.4k4.9m1.8m766.2k162.2k

Accounts Receivable

57.5k38.3k38.9k137.5k232.6k

Inventories

122.2k367.4k231.7k272.2k265.0k241.1k

Current Assets

382.0k631.3k5.4m2.6m2.4m1.5m
Quarterly
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(9.4m)(6.8m)(4.8m)(6.5m)(7.7m)(10.1m)

Depreciation and Amortization

148.8k63.0k78.6k82.4k71.6k147.6k

Inventories

23.0k(245.2k)135.6k(40.5k)7.2k24.0k

Accounts Payable

429.0k1.1m(1.5m)(430.3k)(79.6k)305.2k
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

(1.8m)(4.1m)(6.6m)(3.3m)(1.8m)

Depreciation and Amortization

18.2k41.1k105.6k39.5k259.4k

Inventories

360.7k315.6k301.4k257.7k236.9k256.5k292.2k289.2k249.2k(7.5k)20.4k(13.1k)(48.0k)(55.7k)

Accounts Payable

1.6m1.6m2.5m2.5m1.1m791.7k750.5k648.1k79.3k45.8k25.1k268.6k(13.5k)718.5k
USDY, 2019

Financial Leverage

1.4 x
Show all financial metrics

Predictive Oncology Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
CytoBioscienceAugust 01, 2017

Predictive Oncology Online and Social Media Presence

Embed Graph

Predictive Oncology News and Updates

Predictive Oncology to Report Second Quarter 2019 Financial Results and Provide Company Update on Monday, August 19, 2019

Conference Call to be held August 19, 2019, at 4:30pm Eastern Time Conference Call to be held August 19, 2019, at 4:30pm Eastern Time

Precision Therapeutics’ Skyline Medical Division Expands Presence in Australia with Three New STREAMWAY Systems at Wangaratta Hospital in Victoria

MINNEAPOLIS, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announces its Skyline Medical division, producer of the FDA-approved and CE-marked STREAMWAY® System for automated, direct-to-drain medical fluid disposal, has received an…

Precision Therapeutics’ Skyline Medical Division Widens Global Reach Through New Taiwanese Distribution Agreement with Winner Scientific

Company Further Expands Global Outreach Through Exhibition at Arab Health Show in Dubai Company Further Expands Global Outreach Through Exhibition at Arab Health Show in Dubai

Precision Therapeutics’ Skyline Medical Division Significantly Expands Footprint in New England With Sale of Six STREAMWAY Systems to Yale University Ambulatory Outpatient Surgical Center

Large Sale to Prestigious Health System Further Validates STREAMLINE Utility Large Sale to Prestigious Health System Further Validates STREAMLINE Utility

Predictive Oncology Blogs

Precision Therapeutics Extends Exchange Offer for Helomics Notes and Warrants

MINNEAPOLIS , March 14, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (AIPT) (“Precision” or “the Company”) today announced the extension of its previously announced offer (the “Exchange Offer”) to holders of certain promissory notes (the “Helomics Notes Payable”) of Helomics Holding

Precision Therapeutics’ Skyline Medical Division Captures Market Share in Saudi Arabia Via New Orders While Disposable Sales Show Significant Year-Over-Year Increase

Company Concluded 2018 With 38 Percent Increase in STREAMWAY System Disposables MINNEAPOLIS , March 05, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced that its Skyline Medical division, has entered the African continent, further

Precision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez, MD, PhD

MINNEAPOLIS , Oct. 11, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, has appointed Dr. Hector J. Gomez , President & CEO, Co-Founder of GLG

Precision Therapeutics’ Skyline Medical Division Signs International Distribution Agreement with India-based Prenit World

MINNEAPOLIS , Oct. 09, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) is pleased to announce that its Skyline Medical division, producer of the FDA -approved and CE-marked  STREAMWAY® System  for automated, direct-to-drain medical fluid

Precision Therapeutics Secures First STREAMWAY System Sale in Europe

MINNEAPOLIS , Sept. 27, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”) is pleased to announce it has secured its first European sale of the STREAMWAY System® , an automated, direct-to-drain medical fluid disposal system sold by the Company’s

Precision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory Board

MINNEAPOLIS , Sept. 11, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, is pleased to announce that Dr.
Show more

Predictive Oncology Frequently Asked Questions

  • When was Predictive Oncology founded?

    Predictive Oncology was founded in 2002.

  • Who are Predictive Oncology key executives?

    Predictive Oncology's key executives are Carl Schwartz, David Johnson and Bob Myers.

  • How many employees does Predictive Oncology have?

    Predictive Oncology has 24 employees.

  • What is Predictive Oncology revenue?

    Latest Predictive Oncology annual revenue is $1.4 m.

  • What is Predictive Oncology revenue per employee?

    Latest Predictive Oncology revenue per employee is $58.8 k.

  • Who are Predictive Oncology competitors?

    Competitors of Predictive Oncology include 19Labs, Biotronik and Trimedyne.

  • Where is Predictive Oncology headquarters?

    Predictive Oncology headquarters is located at 2915 Commers Dr #900, Eagan.

  • Where are Predictive Oncology offices?

    Predictive Oncology has an office in Eagan.

  • How many offices does Predictive Oncology have?

    Predictive Oncology has 1 office.